Jacob deGrom

Rangers Notes: deGrom, Seager, Carter, Jung

By Nick Deeds | January 19, 2025 at 1:14pm CDT

Rangers right-hander Jacob deGrom is enjoying the first fully healthy offseason he’s had in quite some time after returning from rehab for Tommy John surgery back in September. As noted by Shawn McFarland of the Dallas Morning News, deGrom spoke to reporters about his outlook headed into the 2025 season and revealed that he’s begun throwing off the mound early this winter. The veteran hopes that building up towards pitching in games more slowly over a longer period of time than he has in the past will help him to stay healthy this season.

The 36-year-old is perhaps the very best pitcher in the entire sport when healthy, but maintaining his health has been a struggle over the past half decade. After winning back-to-back NL Cy Young awards with the Mets in 2018 and ’19 and finishing third during the shortened 2020 season, deGrom got off to an unbelievable start in 2021 with a 1.08 ERA and an eye-popping 45.1% strikeout rate. Unfortunately, he was sidelined in early July with forearm and elbow issues that ultimately ended his season. It’s been more of the same ever since, with deGrom making increasingly brief appearances in the majors each year but nonetheless continuing to dominate whenever he’s on the mound.

Since the start of the 2021 season, deGrom has pitched to a 2.01 ERA (200 ERA+) with a 1.63 FIP and 307 strikeouts in 197 1/3 innings. That would be on a shortlist for the greatest pitching seasons of all time if it hadn’t taken deGrom parts of four seasons to accumulate those numbers, and after watching Jordan Montgomery and Max Scherzer depart from their rotation in back-to-back offseasons the Rangers are surely hoping that they’ll get to see what deGrom can do over a full slate of starts this year. That’s something deGrom is fully on board with, as he told reporters (including McFarland) yesterday that his goal is to make 30 starts this year.

While McFarland notes that deGrom has not yet spoken to Rangers brass about his workload for 2025, the idea of a pitcher with deGrom’s injury history making 30 starts can’t be entirely dismissed. After all, southpaw Garrett Crochet made 32 starts with the White Sox last year despite not having pitched more than 65 innings in a season throughout college and his entire professional career due to injuries and time spent in the bullpen. The White Sox made that possible by aggressively managing his innings throughout the second half. He never recorded an out in the fifth inning this year after the calendar flipped to July and his pitch count maxed out at 77 after the All-Star break. Crochet, of course, is more than a decade younger than deGrom, but this sort of aggressive innings management could allow the Rangers to utilize their ace all throughout the regular season and into the playoffs without him needing to throw anything close to 200 innings.

deGrom isn’t the only key player for the Rangers who is hoping for better health in 2024. McFarland relays that third baseman Josh Jung, outfielder Evan Carter, and shortstop Corey Seager are all healthy and ready for Spring Training next month after undergoing surgeries in the fall. Seager underwent sports hernia surgery back in September but resumed baseball activities in November, while Jung and Carter are on a slightly more delayed timeline after undergoing wrist and back surgery respectively in October.

That trio being healthy and effective in 2025 would be a huge boon for the Rangers who failed to defend their 2023 World Series title in the 2024 postseason in large part thanks to a lackluster offense. Rangers hitters produced a collective wRC+ of just 95 last year as Seager was limited to 123 games by injuries while Jung and Carter managed just 46 and 45 games respectively. Seager remained as effective as ever when healthy enough to take the field with a .278/.353/.521 slash line in 533 trips to the plate, but Jung (102 wRC+) and especially Carter (80 wRC+) struggled to keep up with their expected production even when they were on the field due to the nagging nature of their injuries.

While the club has augmented its offense this winter by bringing in Joc Pederson and Jake Burger to replace Nathaniel Lowe in the lineup, better health from Jung and Carter figure to be necessary if the Rangers hope to look more like their 2023 offense, which was third in baseball with a 116 wRC+, than their below-average 2024 club in the upcoming season. Healthy seasons from Jung and Carter would also come with the benefit of pushing outfielder Leody Taveras and infielder Josh Smith into bench roles, giving them one of the deeper positional groups in the sport when fully healthy.

Rangers Activate Jacob deGrom

By Anthony Franco | September 13, 2024 at 5:57pm CDT

Today: The Rangers have officially activated deGrom to make his first start of the 2024 season. In a pair of corresponding moves, the team optioned right-hander Owen White to Triple-A and transferred Corey Seager to the 60-day IL.

Sept. 10: Jacob deGrom makes his season debut on Friday. The Rangers announced that the two-time Cy Young winner will start that evening’s game in Seattle. It will be his first major league appearance since April 2023. deGrom underwent Tommy John surgery last June.

While deGrom’s return comes too late to give Texas any hope of a playoff push, it’s part of what should be a very exciting series. The Rangers will turn to top prospect Kumar Rocker for his MLB debut in Thursday’s opener. deGrom goes the following night. Manager Bruce Bochy told the beat this evening that Max Scherzer will be reinstated from the 15-day injured list to start on Saturday (X link via Shawn McFarland of the Dallas Morning News). Texas will need to create space on the 40-man roster for both Rocker and deGrom.

deGrom has gotten through four rehab starts within the past few weeks. He has mowed down minor league hitters, striking out 15 while allowing only five baserunners over 10 2/3 innings. deGrom tossed four scoreless innings in just 49 pitches with Double-A Frisco on Saturday. Kennedi Landry of MLB.com wrote over the weekend that the Rangers had envisioned deGrom throwing somewhere around 60 pitches in that outing, though they ultimately elected to cap him at four innings when he pitched so efficiently. That could point to a potential 65-75 pitch count during this week’s start.

The Rangers should get three or four starts from deGrom before the end of the season. They’re not going to be of much significance in the standings (beyond the indirect effect of playing the Mariners, a fringe contender, at least once). Getting deGrom back for a few starts should at least give the pitcher and the front office some comfort going into the offseason. deGrom had battled a handful of arm issues late in his Mets tenure. He only managed six starts and 30 1/3 innings with Texas before suffering the significant elbow injury.

Few players are more important to the Rangers’ hope of a return to contention in 2025. deGrom may still be the best pitcher on the planet when healthy. He was utterly dominant for the Mets when he was able to pitch. He’d carried that form over in his first month in a Texas uniform, working to a 2.67 earned run average while striking out almost 40% of batters faced.

deGrom is going into the third season of a five-year, $185MM free agent deal. He’ll make $40MM next season, followed by successive salaries of $38MM and $36MM through 2027. The Tommy John surgery triggered a conditional team option in his deal for 2028. That’s valued at $20MM, though deGrom could push it to $30MM if he finishes in the top five in Cy Young balloting in any of the next three years.

Scherzer, meanwhile, has been out since the start of August because of a shoulder issue. He’d also missed most of the season’s first half rehabbing offseason back surgery and battling a nerve problem in his throwing hand. Scherzer has been limited to eight starts this season, turning in a 3.89 ERA across 39 1/3 innings. The future Hall of Famer will be a free agent next offseason. Scherzer has already declared he intends to continue pitching; he’ll be one of the top risk/reward plays in the starting pitching class.

Rangers Notes: deGrom, Scherzer, Rocker

By Mark Polishuk | September 8, 2024 at 9:45pm CDT

Jacob deGrom’s 2024 debut finally appears imminent, after the two-time Cy Young Award winner completed his fourth and likely final minor league rehab outing on Saturday. DeGrom has seemingly come out of that four-inning, 49-pitch appearance in good health, and is now set to make his return to the majors at some point during the Rangers’ upcoming six-game road trip that begins Tuesday.

“If it all goes well, he’ll be pitching for us next time around,” manager Bruce Bochy told MLB.com’s Kennedi Landry and other reporters. “It’s pretty cool because it’s been a long road as these guys go through the rehab on the Tommy John.”

DeGrom had his Tommy John surgery in June 2023, and last pitched in a big league game on April 28, 2023. After signing a five-year, $185MM free agent contract with Texas during the 2022-23 offseason, deGrom’s only contribution to the Rangers’ World Series season was six starts and 30 1/3 innings, albeit with a very impressive 2.67 ERA and his typically excellent strikeout and walk rates.

Statistics compiled during minor league rehab stints should always be taken with a grain of salt, but deGrom has looked quite sharp in posting an 0.84 ERA over 10 2/3 total innings in the minors. As Landry noted, deGrom has been so dominant that he hasn’t been able to entirely hit his assigned rehab checkpoints. In his start on Saturday, Bochy said deGrom was assigned for four innings or 60 pitches, yet deGrom breezed through Double-A opponents on just 49 pitches — the most he has thrown in any of his four rehab starts.

As the season enters its final three weeks, the Rangers’ title defense has resulted in only a 70-74 record and a longshot bid at a wild card berth. DeGrom won’t be returning to a pennant race, but there’s some obvious benefit in getting back on a big league mound and shaking off some rust in advance of a hopefully normal offseason, and then a standard ramp-up in Spring Training. At age 36 and with just 186 2/3 MLB innings pitched since Opening Day 2021, deGrom’s health history will always make him something of a question mark, yet he has continued to deliver whenever he has been able to pitch.

DeGrom could soon be joined by another veteran ace in Max Scherzer, whose minor league rehab stint got underway Saturday at Triple-A with four hitless innings of work on 53 pitches. Right shoulder fatigue and then triceps discomfort has kept Scherzer on the injured list since the start of August, but a mechanical fix seems to have corrected his triceps issue, and Scherzer looked to be in good form on Saturday.

It seems possible that Scherzer could rejoin the Rangers as early as this week’s road trip, depending on whether or not the team feels he needs any more rehab work to more fully build his pitch count. The Rangers could also activate Scherzer and then allow him to rebuild at the MLB level, either on a limited innings count or with a piggyback pitcher working behind Scherzer.

Heading into the season, Texas planned to have deGrom, Scherzer (who was then recovering from offseason back surgery), and Tyler Mahle (Tommy John surgery) all back around the middle of the year, providing the rotation with some reinforcements down the stretch. While a few setbacks delayed these pitchers on that projected timeline, the bigger problem was other injuries and a lack of hitting that torpedoed the Rangers’ season.

Ironically, this planned surplus of pitching has now come at a time when the Rangers might prefer to look at their future arms. One such hurler is top prospect Kumar Rocker, who has opened some eyes since his own return from a May 2023 Tommy John surgery. The third overall pick of the 2022 draft has an 0.46 ERA over 19 2/3 innings in Double-A ball this season, and an 1.80 ERA in 10 innings since being promoted to Triple-A Round Rock.

These numbers have been impressive enough that Rangers GM Chris Young told reporters (including Evan Grant of the Dallas Morning News) that the team hadn’t closed the door on the possibility of Rocker making his big league debut at some point before the 2024 campaign is over. Grant ran through the various factors involved, including Rocker’s rough 50-inning cap in his first season back from TJ surgery, and the fact that Texas would be putting Rocker on the 40-man roster perhaps earlier than necessary. With three weeks remaining in the season, there’s still time for Rocker to bank a few more Triple-A innings, and if he keeps forcing the issue, the Rangers still have time to perhaps have the right-hander make a cameo after the minor league season is over.

Jacob deGrom To Begin Rehab Assignment

By Darragh McDonald | August 19, 2024 at 6:04pm CDT

Rangers right-hander Jacob deGrom is set to begin a rehab assignment this week. The righty himself tells Jeff Wilson of Rangers Today (X link) that he’ll likely start for Double-A Frisco on Thursday. Manager Bruce Bochy says that it will either be Thursday or Friday, which will be the first of four rehab outings, per Evan Grant of the Dallas Morning News on X. If all goes according to plan, the righty could be back in the majors by September 10.

deGrom underwent Tommy John surgery in June of last year and is now about 14 months removed from that procedure. Once upon a time, it seemed as though deGrom would be part of a trio of heroes riding in to help the Rangers in the second half of 2024. Tyler Mahle also underwent Tommy John surgery last year and was slated for a midseason return, while Max Scherzer opened the season on the IL after undergoing offseason back surgery.

The 2023 World Series champions hoped that they could stay afloat through the first half of 2024 with a strong offense and a rotation mix consisting of Nathan Eovaldi, Jon Gray, Andrew Heaney, Michael Lorenzen, Cody Bradford, Dane Dunning and others. Ideally, they would have gotten stronger throughout the year and made a strong push in defending their title.

It hasn’t exactly played out that way, unfortunately. The team’s hitters have slashed a collective .239/.308/.381 for a 94 wRC+, putting them ahead of just seven teams in the majors. On top of that, the pitching has been a challenging carousel for the club all year. Due to various ailments, no one on the pitching staff has reached 130 innings pitched yet this year, while Eovaldi and Heaney are the only guys currently on the team with more than 100 frames. Lorenzen was traded to the Royals at the deadline and both Gray and Scherzer are currently on the IL.

The combination of injuries and some struggles around the roster have bumped the Rangers towards the back of the American League playoff race. They are 11 games back of the Astros in the West and then 12.5 games out of a Wild Card spot. The Playoff Odds at FanGraphs give them just a 0.2% chance of cracking the postseason while the PECOTA Standings at Baseball Prospectus are slightly more bullish at 0.8%.

At this point, the club is likely viewing deGrom’s return less as a spark plug for a 2024 postseason push and more about getting a few starts under his belt in preparation for the 2025 campaign. He and the Rangers signed a five-year, $185MM deal heading into 2023, though he’s only been able to make six starts on that deal so far, due to his aforementioned surgery.

The club managed to win the World Series last year even without him, but there’s still three years left on that deal, making him a key part of their next chapter. The righty has been one of the better pitchers in the world over the past decade, though the injuries have been an issue in recent years.

From 2014 to the present, he has a 2.53 earned run average in 1,356 1/3 innings pitched, striking out 31% of batters faced while only walking 5.8%. Among pitchers with at least 700 innings in that time, only Clayton Kershaw has a lower ERA while only Scherzer and Chris Sale topped deGrom in terms of strikeout rate.

In recent years, deGrom has provided even higher quality but with less quantity. He topped 200 innings from 2017 to 2019 but hasn’t even hit 100 since. The 2020 season was shortened to just 60 games by the pandemic and then deGrom missed time in the two subsequent seasons due to right side tightness, right forearm tightness and a stress reaction on his right scapula.

From 2020 to the present, he has tossed 254 2/3 innings with a 2.12 ERA and incredible 42% strikeout rate. That punchout rate is tops among all pitchers with at least 250 innings in that stretch, with Spencer Strider a distant second at 36.9%, while only reliever Emmanuel Clase bests deGrom in the ERA department.

At this point, it’s anyone’s guess what kind of form deGrom will be in when he returns. He is now 36 years old and coming off a lengthy injury absence. He also hasn’t been able to make more than 15 starts in a season since 2019.

The Rangers are set to lose both Scherzer and Heaney to free agency in a couple of months. Eovaldi could be joining them, as his deal has a conditional $20MM player option that he unlocks if he totals 300 innings pitched over 2023 and 2024 or finishes in the top five in Cy Young voting this year. Even if he unlocks that option, he might turn it down and head to the open market since he’s having a strong season and could secure a bigger guarantee over a longer deal in free agency.

If Eovaldi does depart, then the 2025 Ranger rotation on paper is deGrom, Gray, Mahle, Dunning and Bradford, with both Gray and Mahle slated for free agency after next year. Jack Leiter and Owen White are each on the 40-man roster but both have dealt with control problems.

Taken all together, deGrom’s form in the coming years figures to be a significant factor for the Rangers, considering how much they have invested in him and that there’s not a lot of long-term certainty in the rotation picture.

AL Notes: Verlander, Garcia, Buxton, Paddack, Rangers, Skubal

By Mark Polishuk | August 18, 2024 at 10:34pm CDT

Justin Verlander “felt strong” during a bullpen session today in Houston, Astros manager Joe Espada told reporters (including Matt Kawahara of the Houston Chronicle), which should line Verlander up to return to the rotation on Wednesday when the Astros face the Red Sox. A neck strain has kept Verlander from pitching in the majors since June 9, and he has amassed only 57 innings this season due both this current ailment and a bout of shoulder inflammation coming out of Spring Training. However, Verlander has completed two minor league rehab outings and today’s bullpen session looks like the final checkpoint on his path to recovery.

While things are looking promising for Verlander, Luis Garcia is more of a question mark. The Athletic’s Chandler Rome wrote (via X) that as of Friday, Garcia hadn’t yet resumed throwing since he was shut down due to soreness over two weeks ago. This is the second time Garcia has hit a setback in his recovery from Tommy John surgery, and since Garcia went under the knife in May 2023, a normal rehab timeline would’ve had him ready to return to the majors by this point over 15 months past his procedure date. Though the Astros have said Garcia might return as a reliever rather than as a starter, he is running short on time to fully ramp up his readiness to rejoin Houston’s pitching staff in any capacity.

AL West Notes: Verlander, Rodriguez, deGrom

By Mark Polishuk | August 10, 2024 at 2:06pm CDT

Justin Verlander is slated to make a rehab start for Triple-A Sugar Land today, marking his first game action since June 9. Astros manager Joe Espada told reporters (including Matt Kawahara and Matt Young of the Houston Chronicle) that the loose plan is for Verlander to throw three innings or 50 pitches in the first of what is expected to be a two-outing rehab stint, though there’s plenty of fluidity built in as the 41-year-old ace works his way back from a neck strain.

If all goes well, Verlander would likely be activated for the start of the Astros’ series with the Orioles that begins on August 22. Verlander would become the sixth member of a six-man rotation Houston is planning to deploy during a busy stretch of the schedule, as after receiving three off-days within the first 15 days of August, the Astros then play every day from August 16 through September 2. Assuming Verlander returns in his usual top-of-the-rotation form, he’ll be a giant boost to a Houston team that is battling the Mariners for the AL West title, and will again be looking to make another deep playoff run. Between this neck problem and a season-opening bout of shoulder inflammation, Verlander has been limited to 57 innings in his 19th Major League season, but he has a solid 3.95 ERA when available to pitch.

Latest On Rangers’ Rotation, Trade Possibilities

By Steve Adams | July 25, 2024 at 1:36pm CDT

The Rangers have patched together their rotation for much of the season as they anticipate the returns of veterans Max Scherzer, Tyler Mahle and Jacob deGrom. Scherzer has already returned. Mahle is set to make his fifth minor league rehab start today and should make his Rangers debut before long. It’ll be a bit longer before deGrom makes it back, but he tossed a 40-pitch bullpen just yesterday, per Jeff Wilson of RangersToday.com. Left-hander Cody Bradford is on a minor league rehab assignment and expected to return soon, though Evan Grant of the Dallas Morning News writes that he’ll work out of the bullpen upon his return. Texas reinstated righty Dane Dunning from the injured list earlier today, too. He’s in the ’pen for now but could move back to a starting role depending on how the next week goes.

What once was a starting pitching hodgepodge looks increasingly enviable. If Mahle is cleared to return after today’s start, he’ll join Scherzer, Nathan Eovaldi, Jon Gray, Michael Lorenzen, Andrew Heaney and Dunning as viable rotation options, with Bradford in the bullpen and deGrom looming on the horizon. That’s nine MLB-caliber starters, to say nothing of veteran starter Jose Ureña (who started six games but is in the bullpen presently).

With so many options suddenly at their fingertips, there’s been plenty of speculation about the Rangers trading from that stockpile of arms — even as they narrow the deficit in the postseason hunt. Texas has won four straight games. The Mariners have lost three straight. The Rangers now sit only three games back of the first-place Astros in the West and are just 5.5 games out in the Wild Card hunt. They’re not going to operate as a pure seller, but Ken Rosenthal of The Athletic suggests that Lorenzen or perhaps even Gray could be moved before Tuesday’s trade deadline.

Lorenzen, 32, signed with the Rangers on a one-year, $4.5MM deal in spring training. It was a bargain price for a veteran righty coming off a solid season, and he’s proven to be well worth the investment. He’s pitched 97 innings over the course of 17 starts and turned in a 3.53 ERA. Lorenzen’s 18.5% strikeout rate and 11.6% walk rate both leave plenty to be desired and point to some likely ERA regression, but he’s been precisely the type of veteran rotation stabilizer the Rangers hoped to be acquiring when signing him.

As of deadline day, Lorenzen will have just $1.5MM of that base salary yet to be paid out. He’s already picked up $800K of innings-based incentives and will get another $200K when he reaches 100 innings, likely in his next start. Assuming that comes with the Rangers — he’s their probable starter Saturday — a new team would be on the hook for the remaining portion of his base and additional incentives he’d unlock by reaching 120 innings ($300K), 140 innings ($350K), 160 innings ($400K) and 180 innings ($450K). He’s on pace to barely reach that final milestone.

At most, a team adding Lorenzen would pay around $1.5MM in base salary and an additional $1.5MM worth of incentives. If Lorenzen is pitching well enough to reach that 180-inning mark, it’d be considered money well spent. If nothing else, a budget-conscious team looking to add a stable starter (e.g. Twins, Guardians) could view Lorenzen as an affordable option.

Gray would be a more surprising trade candidate. He’s in the third season of a four-year, $56MM contract that’s paying $13MM both this year and next. Thus far, he’s posted 94 innings of 3.73 ERA ball on the season. While Gray’s 19.7% strikeout rate is the lowest of his career (aside from the shortened 2020 season), his 5.8% walk rate is a career-best mark. He’s still averaging 95 mph with his heater, while his opponents’ chase rate and swinging-strike rate are roughly in line with his 2022-23 marks.

Rosenthal also cites a pair of names the Rangers would prefer to hang onto even as they ponder trading from their rotation depth: Eovaldi and Heaney. The former is well on his way to vesting a $20MM player option for the 2025 season. That option would decrease his trade value — a new team would be stuck with the $20MM in the event of a major, post-trade injury. Beyond that, Eovaldi has been one of the team’s best arms this season, notching a 3.31 ERA, 24.6% strikeout rate and 6.1% walk rate in 106 innings. He’d likely be ticketed for their playoff rotation, should they get there. And, even if they don’t, the Rangers might simply hope Eovaldi stays healthy and enjoys pitching in his home state enough that he’d pick up that player option for the 2025 season.

As for Heaney, he’s turned things around after a shaky first season in Texas. The veteran southpaw boasts a 3.60 ERA, 23.5% strikeout rate and 6.8% walk rate in exactly 100 innings. He’s a free agent at season’s end, so one would imagine he’s an on-paper trade candidate in this scenario where Texas deals from its excess. However, the Rangers don’t have an established left-hander in their bullpen. Brock Burke was excellent in 2022 but took a step back in ’23 and was optioned earlier this season after being shelled through 9 2/3 innings. Rookie Jacob Latz has a solid 3.68 ERA in 36 2/3 innings, but he’s walked 13.5% of his opponents. Bradford could possibly fill that role, but he’s yet to return from a stress reaction in his ribcage.

Heaney has experience pitching both as a starter and reliever, including during his time with Texas. He’s throwing well right now but would likely be pushed out of a theoretical postseason rotation. In that setting, he could slide into the bullpen and match up against tough lefties and/or provide multiple innings in long relief.

Max Scherzer Nearing Return; deGrom Throwing Off Mound

By Anthony Franco | June 17, 2024 at 10:59pm CDT

The Rangers dropped their fourth consecutive game in an ugly 14-2 drubbing at the hands of the Mets tonight. That continues a tough month-long stretch that has dropped the defending World Series champions six games below .500.

To the extent there’s a silver lining of Monday for Ranger fans, it’s that the team provided some good news on the injury front. Manager Bruce Bochy told reporters that Max Scherzer’s next start will come at the major league level (X link via Jeff Wilson of Rangers Today). While Bochy didn’t specify a date for the future Hall of Famer’s season debut, it seems likely to fall during this weekend’s series against the Royals.

A herniated disc sent Scherzer to the operating table last December. The initial recovery timeline called for a June or July return. Scherzer seemed to be ahead of schedule early in the year before discomfort in his right thumb slowed his progress. The three-time Cy Young winner restarted a rehab stint on June 9. He pitched twice with Triple-A Round Rock, logging 79 pitches across 4 2/3 innings on Saturday.

Texas has a starting five of Nathan Eovaldi, Jon Gray, Michael Lorenzen, Dane Dunning and Andrew Heaney. Unless Texas opts for a six-man rotation, Scherzer’s return will bump someone from that group to the bullpen. It certainly won’t be Eovaldi or Gray. The Rangers signed Lorenzen to fill a sixth starter/swing role, but he has turned in a 2.86 ERA while working six innings per appearance through 11 starts. Even with middling strikeout and walk numbers, Lorenzen has probably pitched his way into a long-term rotation spot.

Heaney, who’ll take the ball against the Mets on Wednesday, has started 13 of 14 appearances. The southpaw owns a 4.19 ERA with a decent 21.4% strikeout percentage and a strong 6.2% walk rate — similar numbers to those he turned in during his first season in Arlington. Dunning has had a tougher go this season, allowing 4.73 earned runs per nine. While his 26.7% strikeout rate narrowly leads Texas starters, the University of Florida product has issued walks at an uncharacteristic 11.6% clip while struggling with the home run ball.

Scherzer has been joined on the injured list all season by Tyler Mahle and Jacob deGrom. Mahle began facing hitters earlier this month as he works back from last May’s Tommy John procedure. deGrom, who underwent the same surgery in early June 2023, isn’t too far behind. He hit a milestone in his rehab on Monday, throwing off a mound for the first time in 12 months (X link via Shawn McFarland of the Dallas Morning News). deGrom has been targeting a return to MLB action at some point in August.

Injury Notes: Scherzer, Donovan, Lodolo, Chang

By Anthony Franco | March 1, 2024 at 9:08pm CDT

Max Scherzer is one of a trio of key Rangers starters who’ll open the season on the injured list. The three-time Cy Young winner underwent surgery in mid-December to repair a disc herniation in his back. The team announced at the time that the injury would keep him out of action into June or July.

It appears things are going well in the early stages of Scherzer’s rehab process. Manager Bruce Bochy told MLB Network this week the team envisions the star righty being back on an MLB mound by June (X link). The veteran skipper said that’s “a little bit earlier” than the team initially expected. Bochy indicated the club was shooting for a July return for offseason signee Tyler Mahle and a potential August timetable on Jacob deGrom, both of whom are working back from Tommy John procedures.

A few other health notes around the league:

Brendan Donovan is preparing for a rebound after his 2023 season was cut short. An injury to his throwing arm initially required the Cardinals infielder to move to designated hitter. With the team out of contention by the trade deadline, Donovan shut things down and underwent season-ending surgery. While that was initially reported as a flexor tendon repair in his forearm, Donovan clarified to John Denton of MLB.com that he actually had an internal brace procedure to fix the UCL in his elbow (on X). The 27-year-old is back in action this spring and should split most of his time with Nolan Gorman between second base and DH.
Reds starter Nick Lodolo was limited to seven appearances in 2023 because of a stress reaction in his left tibia. That bothersome issue kept him out of action from mid-May on. The southpaw apparently isn’t quite at 100%. Lodolo has yet to make his Spring Training debut because of residual leg discomfort on days after his bullpen or live batting practice sessions, manager David Bell told reporters (link via Gordon Wittenmyer of the Cincinnati Enquirer). The Reds are sending Lodolo for additional testing on the bone before deciding on the next step in his build-up process. That’s at least somewhat alarming, although Bell said the team is still hopeful that Lodolo will avoid opening the season on the injured list.
The Rays lost one of their depth infielders to what’ll be a fairly significant injury. Yu Chang will be out six to eight weeks after suffering an oblique strain, manager Kevin Cash told Marc Topkin of the Tampa Bay Times (relayed on X). That was the concern when the team revealed that Chang was dealing with left side soreness earlier in the week. The defensive specialist is in camp on a minor league contract. He had a shot at securing an Opening Day bench spot, particularly with Taylor Walls opening the season on the IL, but that’s no longer in play. The Rays have declared José Caballero their expected starter at shortstop. Recent free agent pickup Amed Rosario is on hand as a multi-positional option who’d likely be Caballero’s primary backup.

AL Notes: Red Sox, Twins, deGrom

By Nick Deeds | January 28, 2024 at 1:03pm CDT

While adding to the front of the rotation once appeared to be a top priority for the Red Sox this winter, they’ve largely come up short in that regard as they simply swapped Chris Sale out for Lucas Giolito in their rotation mix. More recently, it appears the club has begun looking for other options in their quest to improve the club’s pitching staff. MassLive’s Chris Cotillo reported recently that the club has interest in right-handers Jakob Junis and Codi Heuer.

Junis, 31, defied the odds as a 29th-round pick by the Royals in the 2011 draft and managed to make the majors during the 2017 season. In the years since then, the right-hander has managed to put together a solid career while swinging between the bullpen and the rotation for both Kansas City and San Francisco. While he typically offered roughly league average production for most of his career, Junis enjoyed a career year with the Giants this past season as he pitched to a 3.87 ERA with a 3.74 FIP in 86 innings of work. In 40 appearances for San Francisco last year, Junis struck out a career-best 26.2% of batters faced while walking just 5.7%.

Impressive as Junis was last season, the right-hander is unlikely to be an impactful addition to the Red Sox rotation mix if signed as he tended to pitch most effectively in shorter bursts last year. The righty surrendered a 5.32 ERA in 31 innings of work across nine appearances where he threw 50 pitches or more last year. By contrast, Junis posted a strong 2.95 ERA across 39 2/3 innings of work in 26 appearances where he threw 40 pitches or less. Junis’s success in shorter appearances could make him an interesting relief option for the Red Sox, particularly if the club parts with closer Kenley Jansen before Opening Day.

Heuer, meanwhile, would be more of a speculative addition by the Red Sox. The right-hander last pitched in the majors back in 2021 due to Tommy John surgery and a fractured elbow, but sports a solid 3.56 ERA and 3.66 FIP across 91 innings of work in the majors between the White Sox and Cubs. The righty was nothing short of dominant for the south siders during the 2020 season in particular, as he paired a 50% groundball rate with a upper-90s heater that allowed him to strike out 27.2% of batters faced in 21 appearances. The Cubs non-tendered Heuer earlier this offseason, likely thanks to his two-year layoff from pitching while rehabbing from multiple elbow issues. Still, the 27-year-old hurler has flashed set-up caliber skills during his limited big league appearances and could be a savvy add to the Boston bullpen if healthy.

More from around the American League…

The Twins are lacking in starting pitching depth after losing right-handers Sonny Gray, Kenta Maeda, and Tyler Mahle in free agency earlier this winter, and GM Thad Levine acknowledged that concern during a recent appearance on MLBNetwork Radio. During the appearance, Levine noted that the club feels comfortable with its current starting five of Pablo Lopez, Joe Ryan, Bailey Ober, Chris Paddack, and Louie Varland, but that hasn’t stopped the club from exploring both the trade and free agent markets for other rotation options. Bolstering the club’s rotation mix would not only provide the club with much-needed depth to safeguard against injury but could also give Varland competition for the fifth-starter role, allowing him to return to the multi-inning bullpen role in which he thrived late last season. Michael Lorenzen, Mike Clevinger, and Hyun Jin Ryu are among the mid-level rotation options still available this winter.
Rangers right-hander Jacob deGrom made just six starts for the reigning World Series champions before undergoing Tommy John surgery last spring, but optimism remains at the oft-injured ace will be able to contribute to the club at some point during the 2024 campaign. As noted by Shawn McFarland of the Dallas Morning News, deGrom provided a health update to reporters during the club’s FanFest this weekend. The righty indicated that his arm is feeling good seven months removed from going under the knife and that he currently plans to begin throwing again “sometime this spring.” While deGrom did not mention a timetable for his return to the big league mound, the update tracks with previous comments from the right-hander back in October, which indicated he was targeting a return to the majors in August of 2024. Among the most talented pitchers of his generation, it’s hard to overstate the potential impact deGrom could have for the Rangers this year if he’s available for the stretch run and a potential playoff push. Over his past 108 starts dating back to the 2018 season, deGrom has posted a 2.08 ERA with a near-matching 2.11 FIP and a whopping 921 strikeouts in just 675 2/3 innings of work.

Load More Posts

Show all

Headlines

Jacob deGrom

Navigation

MLBTR INFO

Connect